---
title: "ResMed Inc. Stock Falls Thursday, Underperforms Market"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285618701.md"
description: "Shares of ResMed Inc. (RMD) fell 1.31% to $206.89 on Thursday, underperforming the market as the S&P 500 Index dropped 0.38% and the Dow Jones Industrial Average fell 0.63%. The stock is currently 29.58% below its 52-week high of $293.81, reached on August 22nd. Trading volume was 1.3 million, surpassing the 50-day average of 1.1 million."
datetime: "2026-05-07T20:59:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285618701.md)
  - [en](https://longbridge.com/en/news/285618701.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285618701.md)
---

# ResMed Inc. Stock Falls Thursday, Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of ResMed Inc. (RMD) slipped 1.31% to $206.89 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.38% to 7,337.11 and Dow Jones Industrial Average falling 0.63% to 49,596.97.

ResMed Inc. closed 29.58% short of its 52-week high of $293.81, which the company reached on August 22nd.

Trading volume (1.3 M) eclipsed its 50-day average volume of 1.1 M.

Data source: Dow Jones Market Data, FactSet. Data compiled May 7, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

05-07-26 1659ET

### Related Stocks

- [RMD.US](https://longbridge.com/en/quote/RMD.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)
- [RMD.AU](https://longbridge.com/en/quote/RMD.AU.md)

## Related News & Research

- [Jenscare’s LuX-Valve Plus Shows Strong One-Year Results in Large Annulus Tricuspid Patients](https://longbridge.com/en/news/287144318.md)
- [ResMed Earnings Preview: What to Expect](https://longbridge.com/en/news/281019552.md)
- [Edwards Lifesciences CVP, Strategy/Corp Development Sold Shares Worth Over $1.4M](https://longbridge.com/en/news/286822028.md)
- [Medtronic announces intent to acquire SPR Therapeutics, Inc., expanding care options for people living with chronic pain | MDT Stock News](https://longbridge.com/en/news/287072903.md)
- [Orthofix Medical updates 2026 outlook after CMS Medicare cuts for bone growth stimulators](https://longbridge.com/en/news/287216169.md)